Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis

Bibliographic Details
Main Authors:	Tchilian, E, Desel, C, Forbes, E, Bandermann, S, Sander, C, Hill, A, Mcshane, H, Kaufmann, S
Format:	Journal article
Language:	English
Published:	2011

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
by: Tchilian, E, et al.
Published: (2009)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Delta ureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis, (vol 77, pg 630, 2009)
by: Tchilian, E, et al.
Published: (2011)

The recombinant BCG ΔureC::hly vaccine targets the AIM2 Inflammasome to induce autophagy and inflammation
by: Saiga, H, et al.
Published: (2014)

Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
by: Martin Gengenbacher, et al.
Published: (2016-07-01)

Dietary Pyridoxine Controls Efficacy of Vitamin B<sub>6</sub>-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Δ<italic toggle="yes">pdx1</italic> in Mice
by: Martin Gengenbacher, et al.
Published: (2014-07-01)

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
by: Pathan, A, et al.
Published: (2007)

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
by: Pathan, A, et al.
Published: (2007)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
by: McShane, H, et al.
Published: (2004)

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
by: Ansar A Pathan, et al.
Published: (2007-10-01)

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials.
by: Ansar A. Pathan, et al.
Published: (2011-01-01)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
by: Stylianou, E, et al.
Published: (2015)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
by: Williams, A, et al.
Published: (2005)

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
by: Scriba, T, et al.
Published: (2010)

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials
Published: (2011-01-01)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle.
by: Gillian S Dean, et al.
Published: (2015-01-01)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
by: Vordermeier, H, et al.
Published: (2009)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
by: Mcshane, H, et al.
Published: (2005)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
by: de Cassan, S, et al.
Published: (2010)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
by: Vordermeier, H, et al.
Published: (2011)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
by: Enric Vidal, et al.
Published: (2017-08-01)

Evaluation of immunogenicity and protective efficacy elicited by Mycobacterium bovis BCG overexpressing Ag85A protein against Mycobacterium tuberculosis aerosol infection
by: Zheng Zhong Xu, et al.
Published: (2016-01-01)

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
by: Wajja, A, et al.
Published: (2024)

Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
by: Rosario, M, et al.
Published: (2010)

Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.
by: Ana Balseiro, et al.
Published: (2017-01-01)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
by: Mcshane, H, et al.
Published: (2001)

Molecular identification of Proteus mirabilis, Vibrio species leading to CRISPR-Cas9 modification of tcpA and UreC genes causing cholera and UTI
by: Muhammad Naveed, et al.
Published: (2024-04-01)

Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
by: Yong Woo Back, et al.
Published: (2019-01-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
by: Harris, SA, et al.
Published: (2014)

Proteoliposomes from mycobacterium bovis BCG and mycobacterium smegmatis as new vaccine candidates against tuberculosis
by: Kadir, Ramlah
Published: (2016)

Tuberculosis vaccine strain <it>Mycobacterium bovis </it>BCG Russia is a natural <it>recA </it>mutant
by: Böttger Erik C, et al.
Published: (2008-07-01)

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
by: Scriba, T, et al.
Published: (2011)

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A (vol 17, pg 1066, 2010)
by: de Cassan, S, et al.
Published: (2011)

Prevalence of Specific Helicobacter Pylori cagA, vacA, iceA, ureC Genotypes and its Clinical Relevance in the Patients with Acid-Peptic Diseases
by: Himani Bhardwaj Pandya, et al.
Published: (2017-08-01)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
by: Vordermeier, H, et al.
Published: (2011)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
by: Goonetilleke, N, et al.
Published: (2003)

Frequency of hlyA, hlyB, hlyC and hlyD genes in uropathogenic Escherichia coli isolated from UTI patients in Shiraz
by: Moeinizadeh, Heliyaneh, et al.
Published: (2021-08-01)

New tuberculosis vaccines can diminish as well as enhance BCG induced protection: Results from a murine model
by: Sander, C, et al.
Published: (2006)

Complement Dependent and Independent Interaction Between Bovine Conglutinin and Mycobacterium bovis BCG: Implications in Bovine Tuberculosis
by: Arshad Mehmood, et al.
Published: (2019-02-01)

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
by: Verreck, F, et al.
Published: (2009)

Vaccination against tuberculosis: how can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis

Similar Items

Similar Items